Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

Bombardier has minimal exposure to the military end market when compared with its closest peers ... which reflects Bombardier’s relatively high cost of equity and cost of debt, owing to its moderate ...

The world’s richest man has lavished time, attention and tens of millions of dollars on Trump’s reelection. And it’s not for nothing.